Power Law company profile

Stereotaxis

Health Tech & Medtech · St. Louis, United States · Founded 1990 · IPO 2004 Colt

Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases

Valuation

$180M

Market cap · May/2026

Revenue

$32M

Latest reported FY

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

6 investors on Stereotaxis's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage

A.G. Edwards & Sons

DFJ Portage Ventures

Advantage Capital

Alafi Capital

Stifel

Ascension

Global footprint

Where Stereotaxis has talent and traffic

Workforce by country

🇺🇸 United States · St. Louis HQ

Book a demo for the full country breakdown

Web traffic by country

4.3K monthly visits
across markets

🇺🇸 United States88.4%

🇮🇳 India9.3%

🇩🇪 Germany0%

Top 3 markets shown

Market sentiment

What the market is saying about Stereotaxis

An AI-synthesized read of the highest-engagement posts about Stereotaxis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Stereotaxis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles